Article Details
Retrieved on: 2025-04-04 11:08:21
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Number 2: Monoclonal antibodies lead biosimilar approvals because of their large market size, well-defined regulatory pathways, and technological ...
Article found on: www.centerforbiosimilars.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here